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Reversible phosphorylation of proteins represents an important component of cellular
signaling pathways. The isolation of phosphoproteins in complex mixtures and the determi-
nation of the level of phosphorylation have been and remain a major challenge. It has
prompted the development of several strategies, including immobilized metal affinity capture
to enrich for phosphorylated peptides. An improved methodology was published (Ficarro, et
al., Nature Biotechnology 2002, 20, 301–305) that showed increased selectivity through
esterification of amino acid side chain carboxylic groups of enzymatically digested peptides.
This method was applied for relative quantitation of phosphopeptides in conjunction with the
use of stable isotope labeling. The merits and limits of the approach are discussed and its
application to the analysis of the effects of serum starvation on in vitro cultured human lung
cells is presented. (J Am Soc Mass Spectrom 2004, 15, 363–373) © 2004 American Society for
Mass Spectrometry
Cellular signaling pathways exploit both revers-ible and non-reversible posttranslational modi-fications of proteins for signal transmission.
Phosphorylation is one of the most common and well-
studied reversible modifications. Phosphorylation oc-
curs, predominantly on serine, threonine, and tyrosine
residues, and is catalyzed by kinases. Conversely de-
phosphorylation requires phosphatases. In some cases
the activity of these enzymes is triggered by phosphor-
ylation, which play an important role in signal cascade
[1]. Thus, the determination of the phosphorylation
state of proteins not only reveals kinase substrates but
in some cases also provides information on the activa-
tion state of these enzymes.
One classic approach for characterizing protein
phosphorylation relies on [32P]-labeling, followed by
two-dimensional gel electrophoresis [2]. Typically gel
spots of interest containing phosphorylated proteins are
excised, digested, and analyzed by Edman sequencing
or mass spectrometry. Over the years, several strategies
have been developed that increase the sensitivity of
phosphoproteome analysis and eliminate the need for
radioactive labeling.
Most mass spectrometric based strategies for charac-
terizing phosphoproteins in complex mixtures include
tryptic digest of the protein, extensive fractionation,
and selective enrichment for phosphopeptides. The
subsequent mass spectrometric analysis aims at identi-
fying the phosphopeptides present in the mixture, and
determining the phosphorylation sites. Variations in
abundance of phosphorylated proteins from cell popu-
lations (e.g., grown under different conditions) can be
studied by using stable isotope labeling methods, now-
adays commonly used in proteomics studies. Phos-
phopeptide detection by peptide mapping preceding
and following enzymatic dephosphorylation circum-
vents the poor ionization efficiency of phosphopep-
tides. Larsen et al. have reported enzymatic dephos-
phorylation of complex peptide mixtures directly on a
matrix assisted laser desorption ionization (MALDI)
target [3].
Phosphopeptides have characteristic fragmentation
patterns and have been identified based on the presence
of specific marker ions in negative ion mode: m/z 63 and
m/z 79 for PO2
 and PO3
, respectively. In positive ion
mode, the loss of 80 Da from tyrosine-phosphopeptide
ions, compared to a loss of 98 Da for serine- and
threonine-containing phosphopeptides, is indicative of
the amino acid carrying the phosphate group. The
presence of phosphotyrosine residues can also be con-
firmed by its characteristic phosphorylated immonium
ion at m/z 216, while serine and threonine group do not
produce such fragments [4].
Collision induced dissociation (CID) and post-source
decay (PSD) techniques have been widely used to
derive site of phosphorylation and peptide sequence
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information of phosphopeptides. Multicharged precur-
sor ions are preferred for CID analysis to limit loss of
the phosphate group [5, 6]. The use of a MALDI
instrument equipped with infrared laser was shown to
enhance PSD of phosphopeptide [7]. Recently, electron
capture dissociation (ECD) [8], which yields primarily c
and z peptide backbone ion series, was employed to
analyze posttranslational modifications [9] and was
applied to the study of phosphopeptides [10, 11].
On-line HPLC separation combined with mass spec-
trometric analysis using neutral loss and precursor ion
scanning has been introduced as a fast method to
identify posttranslational modifications of peptides in
complex mixtures [6, 12, 13]. Phosphopeptides present
in collected HPLC fractions were subsequently charac-
terized by ESI-MS/MS or MALDI PSD sequencing [14,
15]. The introduction of nanoelectrospray has increased
the sensitivity of the technique [6, 16]. An alternative
and highly sensitive method, which involves using an
online HPLC inductively coupled plasma mass spectro-
metry strategy, has been reported to allow the detection
of [31P] with a sensitivity of 0.1 pmol [17]. A parallel
HPLC-electrospray mass spectrometry experiment was
carried out to identify the phosphopeptides.
The analysis of differential levels of phophorylation
in proteins (e.g., normal versus disease tissues or cells)
has been reported using stable isotope incorporation.
The stable isotopes are incorporated either by metabolic
labeling with 15N [18] or by multi-step chemical label-
ing, which typically involves a -elimination of the
phosphate group (or O-glycan), followed by Michael
addition of an isotope coded tag [19, 20].
The improvement of the method by attaching a
biotin affinity tag via linker to the phospho peptide was
proposed to enrich for this class of proteins [19, 21, 22].
However, quantitation might be compromised due to
partial -elimination in the case of threonine residues,
and phosphotyrosine peptides will not be detected
using this method. Furthermore, O-glycosylated pep-
tides also undergo -elimination, and be indistinguish-
able from phosphopeptides. Zhou et al. have proposed
an alternative six-step chemical method to overcome
these problems that includes protection of terminal
groups, followed by deprotection to generate phospho-
ramidate thiol derivatives. These products can be cap-
tured on solid phase support with a high degree of
selectivity prior to LC/MS/MS for identification. The
limitation of this approach is the potential sample loss
when applied to trace amounts of material due to the
numerous steps involved [23].
The typically low abundance of phosphopeptides
and their inferior ionization efficiency in complex mix-
tures has prompted the development of several alterna-
tive enrichment methods. Early strategies have lever-
aged antibodies with specificity for phospho-serine,
threonine, and tyrosine, which were primarily used for
visualization in 2-D western blots, as reviewed in [24].
While high sensitivity has been demonstrated (in the
low fmol range for visualization), variable antibody
specificity, e.g., due to steric hindrance, has limited the
use of this method. Kalo and Pasquale reported on
enrichment of phosphotyrosine containing peptides us-
ing a multi-antibody approach, followed by analysis
with MALDI-MS [25]. Alternatively, a technique that
involves the binding of phosphopeptides to immobi-
lized metal ions (Fe3 and Ga3) [26] has been widely
utilized to enrich phosphopeptides for subsequent mass
spectrometric analysis [27–33]. Posewitz and Tempst
reported good binding of phosphopeptides using Ga3
metal ions. Zhou et al. found that a higher sensitivity is
achieved for monophoshorylated peptides using Fe3,
while Ga3 yielded a better result for multiply phos-
phorylated peptides [28, 34]. A major drawback of
immobilized metal affinity chromatography (IMAC)
enrichment is the nonspecific binding of peptide due to
negative charges of the carboxylic groups at C-termi-
nus, aspartic acid or glutamic acid side chains. Hunt’s
group reported a major improvement of the method by
derivatizing the free carboxyl groups, which are re-
sponsible for the non-specific binding of acidic unphos-
phorylated peptides on an IMAC column [35]. Esterifi-
cation of the free carboxylic groups under acidic
conditions (MeOH/HCl) removes negative charges and
increases specificity for enriching phosphopeptides.
This study was carried out to analyze phosphoryla-
tion states through the use of stable isotope derivatives
and outline some of the experimental strengths and
weaknesses of the approach through the analysis of
model peptide mixtures [while this manuscript had
been submitted and was being reviewed, a similar
approach was reported [38]. Furthermore, the approach
was further applied to compare IMAC enriched phos-
phopeptides from in vitro cultured human lung cells
under standard culture and following serum starvation.
Experimental
Chemicals and Materials
Human serum albumin, apo-transferrin, chicken ly-
sozyme, and bovine -casein, acetyl chloride, anhy-
drous methanol, iron chloride (III), iodoacetamide, cal-
cium chloride, dithiothreitol (DTT), and formic acid
were purchased from Aldrich-Sigma (St. Louis, MO).
The phosphopeptides p60c-src peptide 521-533, p60c-
src substrate II, and calcineurin substrate were obtained
from Calbiochem (San Diego, CA). Methanol-d3 was
purchased from C/D/N (Pointe-Claire, Quebec, Can-
ada). Methanolic HCl (0.5 N and 3 N) was purchased
from Supelco (Bellefonte, PA). Sodium phosphate diba-
sic, acetic acid (AcOH), acetonitrile (ACN), and isopro-
pyl alcohol were purchased from EM Science (Gibbs-
town, NJ). Trifluoroacetic acid (TFA) and TPCK-
modified trypsin were purchased from Pierce
(Rockford, IL). POROS R2 column (POROS R2/10, 4.6
 50 mm) and POROS MC column (2.1 30 mm, IMAC
column) were purchased from Applied Biosystems
(Framingham, MA) and reversed-phase HPLC columns
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were obtained from Vydac (Hesparia, CA). DC protein
assays were purchased from BioRad (Richmond, CA).
Methods
Protein precipitation. Protein mixtures were precipi-
tated using 5 mL methanol/acetone (4:1, vol/vol) mix-
ture and centrifuged at 7400 rpm (9000 g) for 15 min at
4 °C. The supernatant was decanted and discarded and
the protein pellet was redissolved in 1 mL of 5 M
guanidine-hydrochloride solution in 100 mM Tris-HCl
buffer, pH 8 containing 5 mM DTT.
Cell lysate preparation. The lung adenocarcinoma cell
line NCI-H1299 was cultured in RPMI medium supple-
mented with 10% FBS, 1 mM sodium pyruvate, 10 mM
HEPES and 1 penicillin-streptomycin. The H1299 cells
at passage 5 were grown to 80% confluency. The cells
were washed three times with PBS and incubated for
96 h in medium without serum. Serum-free media was
changed once during the starvation period. After serum
starvation, the cells were incubated for 6 h in either
medium without serum or medium with serum. Cells
were washed twice with PBS and harvested with
versene (0.02% in HBSS). Cells were greater than 85%
viable as determined by PI exclusion using flow cytom-
etry. Cells were lysed in 10 ml of lysis buffer (0.125 mM
Tris pH 7.4, 150 mM NaCl, 2% SDS, 0.5% NP-40, 0.25%
sodium deoxycholate, 1:100 dilution of Sigma phospha-
tase inhibitor cocktails 1 and 3 and Sigma protease
inhibitor cocktail) by vortexing, shearing through an
18-gauge needle and incubation for 30 min at 4 °C. A
detergent compatible protein assays was done to deter-
mine protein concentration.
Tryptic digestion and reversed phase cleanup. A mixture
of model proteins (2 mg each) was dissolved 1 mL
solution containing 5 M guanidine-hydrochloride in 100
mM Tris buffer, pH 8 and 5 mM DTT. The solution was
heated to 90 °C for 5 min and was further incubated at
37 °C for 30 min. Iodoacetamide (10 L, 1.1 M) was
added to the reaction mixture and the sample was
incubated for 1 h at room temperature in the dark.
Dithiothreitol was added to quench the reaction. The
sample was diluted tenfold with a solution containing
50 mM CaCl2 and 100 mM Tris-HCl, pH 8. Digestion
was performed by adding 500 g TPCK-modified tryp-
sin and the mixture was incubated for 18 h at 37 °C. The
digestion was quenched by adding 35 L TFA. Digested
protein mixture was loaded onto a POROS R2 (0%
acetonitrile). Peptides were eluted with 40–50% aceto-
nitrile gradient with 0.1% TFA. The eluate was ali-
quoted into 500 g fractions and concentrated under
vacuum.
Esterification of peptides. The reagent was prepared by
adding 90 L acetyl chloride dropwise to 2 mL anhy-
drous MeOH. Deuterited reagent was prepared as
described above using methanol-d3. The peptide digest,
typically 500 g, was thoroughly dried prior to esteri-
fication reaction and reacted with 500 L of methanolic
HCl at room temperature for 20 min (or as specified
under Results and Discussion). The reagent was re-
moved by evaporation under vacuum.
Immobilized metal affinity capture. The sample was re-
constituted in 100 L 0.1% AcOH. The POROS MC
column was equilibrated with 0.1% AcOH on an Agi-
lent 1100 HPLC system with a flow rate of 200 L/min.
The column was conditioned twice by injecting 100 L
of 100 mM EDTA, 1 M NaCl, pH 8.5, and subsequently
equilibrated with 0.1% AcOH for 6 min. The ion loading
(200 L of 100 mM FeCl3 in 0.5% TFA) was done at a
flow rate of 100 L/min. Unbound ions were removed
by washing the column with 0.1% AcOH for 5 min at
200 L/min. The peptide mixture was injected with a
reduced flow rate of 50 L/min and flow-through
fractions were collected. The column was washed with
30% ACN in 0.1% AcOH at a flow rate of 200 L/min
for 5 min. The bound peptides were released by inject-
ing 200 L of 100 mM phosphate buffer, pH 7.5. The
fractions containing the phosphopeptides were col-
lected according to their UV absorption and evaporated
to dryness under vacuum. The bound fractions were
Scheme 1. Enrichment and stable isotope labeling work flow for quantitative analysis of phos-
phopeptides.
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further desalted by reversed-phase HPLC with a Vydac
C18 column (50 mm  0.3 mm).
Reversed phase HPLC/MS and HPLC/MS/MS. Reverse
phase HPLC separation was performed on an Agilent
1100 system (Palo Alto, CA) set to a flow rate of 2
L/min. The system was equipped with a C18 precol-
umn (50 mm  0.15 mm) in conjunction with a switch-
ing valve for desalting, and a C18 analytical column
(150 mm  0.15 mm) for peptide separation. MS and
MS/MS analyses were performed on a ThermoFinnigan
LCQ Deca (San Jose, CA) quadrupole ion trap mass
spectrometer. The spray voltage was set at 4.6 kV, and
capillary temperature at 175 °C. The LCQ data acquisi-
tion was performed in triple-play mode over m/z range
of 400–2000  and the MS/MS spectra of the three most
intense peaks were collected after one survey (MS) scan.
Alternatively, analyses were performed on a Q-Star
mass spectrometer (MDS/Sciex, Toronto, Canada). The
data acquisition time was set to 3 s per spectrum over a
m/z range of 400 to 1500 Da for LC/MS analyses. The
ion spray voltage was set at 5.2 kV.
Peptide identification and quantitation. Data were pro-
cessed using the Pro ICAT program (Applied Biosys-
tems, Foster City, CA/MDS/Sciex). It allows determi-
nation of the relative abundance of heavy and light
labeled peptides. The quantitation of light and heavy
derivative pairs is performed in full spectral and chro-
matographic mode. The quantitation results are stored
in a database (Microsoft Access) and curated manually
by extracting ion chromatograms (XICs) for ion pairs of
interest. The peptide identification was performed by
submitting the experimental MS/MS spectra to a data-
base search using Mascot [36] and Scope [37] as search
engine. The search parameters were set to take into
account of amino acid mass increase due to esterifica-
tion, and variable modification parameters were set to
allow esterification and phosphorylation of peptide.
Figure 1. Base peak mass chromatograms of the fractions retained on the IMAC column prepared
from a mixture of four proteins (see Experimental), (a) without esterifcation treatment and (c) after
esterification with a 1:1 mixture of light (d0) and heavy (d3) reagent (acidic methanol). The mass
spectra from averaging the region of elution of the phosphopeptide (sequence FQpSEEQQQT-
EDELQDK) peak is shown in (b) without esterification and (d) with esterification.
Figure 2. Correlation of phosphopeptide quantity (sequence:
H-TSEPQpYQPGENL-OH) loaded on an IMAC column (2.1  30
mm) and UV absorbance (214 nm). The data shown are the
average of two analyses.
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Results and Discussion
The analysis of phosphopeptides requires multiple
stages of sample processing. The overall strategy pro-
posed to quantitatively analyze phosphopeptides is
depicted in Scheme 1. Cells or tissues from two different
states are esterified in parallel with methanolic HCl
using either methanol -d0 or -d3 to yield light and heavy
labeled peptides, respectively. The two samples are
then combined and subjected to immobilized metal
affinity capture (IMAC) to selectively enrich for phos-
phopeptides. The fraction containing the peptides is
eluted from the IMAC column with phosphate buffer
and analyzed by LC/MS. The resulting LC/MS data
were processed using the ProICAT program to identify
pairs of d0 or d3 labeled peptides. The differentially
phosphorylated peptides (i.e., twofold over or under
expressed) were sequenced by MS/MS. The experimen-
tal set up is based on an inclusion list generated from
differential analysis and results in acquiring exclusively
peptides of interest.
The major drawback of the immobilized metal affin-
ity capture that has been used over the past decade is
the non-specific binding of acidic peptides containing
multiple aspartic acid or glutamic acid residues. The
product of IMAC capture is still a complex mixture of
phosphorylated and non-phosphorylated peptides.
Derivatization of the carboxyl groups of the side chains
and at the C-terminus has been reported to overcome
the problem by significantly reducing the non-specific
binding on IMAC columns [35]. We have expanded this
approach by using it in conjunction with normal (d0) or
labeled (d3) MeOH-HCl for esterification under acidic
conditions. This method was tested with a protein
mixture containing human serum albumin, apo-trans-
ferrin, chicken lysozyme, and bovine -casein. This
protein mixture was digested with trypsin and divided
Figure 3. Analysis of methanol (d0/d3) esterified phosphopeptides in a complex mixture. Extracted
ion chromatograms of light (d0) (b) and heavy (d3) (a) methanol-esterified phosphopeptide spiked into
a four-protein mixture digest and their mass spectra (c–e). The ratios of phosphopeptides added in
light over heavy methanol esterification mixture are: 1:1 (a–c), 1:10 (d), and 10:1 (e).
Table 1. Quantitative analysis of IMAC bound fraction using ProICAT
Elution time
(min)
m/z
Light
m/z
Heavy z
No. methyl
groups
Area
light
Area
heavy
Ratio
heavy/light
58.9 793.37 797.89 2 3 46,855 59,072 1.26
60.3 793.38 797.91 2 3 198,515 20,612 0.10
60.9 793.38 797.90 2 3 21,567 185,641 8.61
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into two fractions, one being subjected to esterification
and subsequent IMAC capture, the second being di-
rectly loaded on an IMAC column. In both cases the
phosphor-peptides were eluted off the IMAC column
with phosphate buffer and analyzed by LC/MS using a
C18 reversed phase column. A much larger number of
components was observed in the case of the non-
esterified sample, indicating significant nonspecific
binding on the IMAC column (Figure 1a). For instance,
numerous peptide signals were observed in the mass
spectrum recorded at the elution time (42 min) of the
phosphopeptide derived from bovine -casein (FQpSE-
EQQQTEDELQDK). (Figure 1b). The corresponding
esterified sample exhibited a drastic reduction of com-
plexity after IMAC capture. As shown in Figure 1c,
partially derivatized by-products were observed in ad-
dition to the major product, as seven carboxylic groups
had to undergo esterification. It has also to be noted that
the quality of the mass spectrum corresponding to the
major product was greatly enhanced through esterifica-
tion as shown in Figure 1d. All peptides are observed as
doublet since the peptides derived with normal and
d3-labeled methanol were added in a 1:1 ratio. These
results clearly demonstrated the necessity and effective-
ness of esterifying the carboxyl groups for phosphopep-
tides enrichment by immobilized metal affinity column.
In spite of partially esterified peptides present, the
ratios of heavy to light labeled phosphopeptides are
maintained as 1.0, suggesting the quantitation has not
been compromised due to the incomplete esterification.
Figure 4. MS/MS spectra of peptides with side-reaction on asparagine residues. Lysozyme tryptic
peptides were methyl-esterified for 120 min. The peptide sequences are shown on the spectra together
with the fragment ion masses expected with methyl esterification only and deamidation followed by
methyl esterification on the indicated asparagines residues. Bold letters indicate desired esterification
sites and underlined letters signify side reaction sites. Data were acquired on an ion trap mass
spectrometer.
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The conditions for immobilized metal affinity cap-
ture were further optimized in order to quantitatively
enrich phosphopeptides. As illustrated in Figure 2,
under optimum conditions the HPLC analysis showed
a linear response for various amounts of sample (phos-
phopeptide p60c-src peptide 521–533) subjected to es-
terification, and followed by capture on an IMAC
column. The average signal area observed in a UV
chromatogram (  214 nm) showed linearity from 2.5
to 10 micrograms of phosphopeptide loaded.
The esterification with normal and d3-labeled methyl
groups allows for a comparative analysis of two sam-
ples, as the determination of the relative abundance of
both peptides isotopomers is straightforward. The ap-
plicability of the method to analyze differentially phos-
phorylated peptides was probed by adding a model
compound (phosphopeptide p60c-src peptide 521–533)
to a four-protein mixture digest. The test phosphopep-
tide was esterified with d0 and d3 labels specifically,
mixed in various ratios 1:1, 1:10, and 10:1 (d0:d3), added
to the peptide digest and captured on an IMAC column.
The bound fractions were eluted with phosphate buffer,
desalted and subsequently analyzed by LC/MS. The
data were processed using the Pro-ICAT program in
order to detect pairs of peptides and accurate quantita-
tions of their relative abundance were performed by
extracting the ion chromatograms of corresponding
ions. The ion chromatograms for the phosphopeptide
(TSTEPQpYQPGENL) derived with light and heavy
reagents (m/z 793.36, 797.90, respectively) mixed in a 1:1
ratio are shown in Figure 3a and b, respectively. The
mass spectra for other light to heavy ratios are pre-
sented in Figure 3c–e. The results of these analyses are
summarized in Table 1. There is a good agreement with
the expected values (i.e., 1.0, 0.1, and 10.0). These results
clearly demonstrate that differential analysis of phos-
phopeptides using stable isotope labeling through es-
terification combined with immobilized metal affinity
chromatography enrichment is feasible.
In order to assess the efficiency of the derivatization
step, the esterification reaction was carried out under
various conditions. Reaction times ranging from 20 to
120 minutes were used to derivatize a tryptic digest of
chicken lysozyme. Fully esterified peptides were ob-
served as the major product at all time points studied.
In addition to the esterification of the carboxyl groups,
minor amount of deamidation products were observed
as the side reaction occurring at asparagine and glu-
tamine residues. Under the acidic conditions to esterify
the carboxylic groups, aspartic acid and glutamic acid
residues might undergo solvolysis, and subsequently
be converted into methyl ester. The reaction was ob-
served even after extensive drying of the peptide mix-
ture prior to reaction with anhydrous methanol/HCl.
Conditions were further tuned to minimize this side
reaction as much as possible as it would change the
amino acid composition, while keeping high yields of
esterification. The MS/MS spectra shown in Figure 4a
and b illustrate the side reaction occurring at asparagine
residues. Figure 5a and b show the relative amount of
the incomplete methylation and deamidation products
for two tryptic peptides from lysozyme (Sequences:
NTDGSTDYGILQNSR and FENSNFNTQATNR). The
amount of by-products was minimized (5 to 10%) by
using a reaction time ranging between 20 and 40
minutes, which is significantly shorter than previously
described [35].
As a proof-of-principle of applicability of this ap-
proach to biological samples, we analyzed phosphopro-
teins present in a human lung cancer cell line (NCI-
H1299). A serum starvation experiment was carried out
with cultured cells. The cell lysates from serum-de-
prived cultures were esterified with normal methanol,
while the cell lysates from serum stimulated cultures
were treated with methanol-d3. The MS/MS spectrum
Figure 5. The relative intensity (by XIC of interest ions) of
incomplete-reaction and side-reaction for the peptides (NTDGST-
DYGILQINSR) (a) and (FESNFNTQATNR) (b) with side-reaction
on asparagine residues at different reaction times (20, 40, 60, and
120 min). The MS/MS spectra obtained from the peptides modi-
fied on asparagine residues after the 120 min reaction are shown
in Figure 4.
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of the d0 labeled phosphopeptide derived from hetero-
geneous ribonuclear particle protein A1 is shown in
Figure 6. The insert represents the molecular region of
d0 and d3 labeled species. Analysis of the data allowed
detection of numerous pairs of d0/d3 methylated pep-
tides. A selected subset of peptide ions was subjected to
MS/MS in order to determine the amino acid sequence.
The results are summarized in Table 2, including the
ratio of their relative abundance in cells grown under
stimulated conditions and cells deprived from serum.
The ratios listed were obtained by averaging the results
from three independent experiments performed on the
same biological sample including all the steps, i.e.,
esterification, IMAC capture, and LC/MS analysis. The
low coefficient variation values listed in Table 2 (with
an averaged %CV of 12%) reflect the good reproduc-
ibility of the process in spite of its complexity, due to
multiple derivatization and fractionation steps. These
results demonstrate that stable isotope labeling through
esterification of carboxyl groups provides an effective
way to determine relative abundance of phosphopep-
tides and to determine the amino acid sequence and
subsequently identify the sites of phosphorylation.
Conclusion
The approach described earlier by Ficarro et al. [35] that
convert free carboxyl groups into methyl ester deriva-
tives represents a major improvement over prior immo-
bilized metal affinity capture methods for the analysis
of phosphopeptides. The removal of the negative
charges at C-terminal, aspartic acid or glutamic acid
side chains greatly reduces nonspecific binding during
the immobilized metal affinity capture of phosphopep-
tides. However, the esterification step that enables this
improvement has some drawbacks. Due to the presence
of residual water, asparagines and glutamine residues
may undergo deamidation and be subsequently be
converted into methyl ester. This side reaction results in
alterations of amino acid composition, which translated
in two concomitant mass changes for one single amino
acid (NH2 to OH, OH to OMe). It constitutes a signifi-
cant complication for the algorithm used to search
MS/MS spectra against a database. Consequently, ex-
perimental conditions have been carefully established
to minimize side reactions. As methyl esterification
reaction can be performed with various stable isotope
labeled alcohols, we demonstrated the utility of this
approach using d0- and d3-methanol with test mixtures
of proteins. The method was tested on samples isolated
from cells that were cultured under a classic serum
starvation experiment. The results demonstrated that
stable isotope labeling through esterification provides
an effective way to quantify relative abundance of
phosphopeptides and to determine the amino acid
sequence and the sites of phosphorylation.
Figure 6. MS/MS spectra of phosphopeptide (SEpSPKEPEQLR) containing 4 methyl esterfied
residues from human NCI-H1299 lung cancer cell. The insert is the MS spectrum showing the
differential of d0 and d3 labeled phosphopeptides.
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Table 2. Phosphopeptides quantitation and identification from human NCl-H1299 lung cell line1
H/L Ratio2
(average)
Standard
deviation %CV
tR
[min] (L) m/z (H) m/z z
No. methyl
group Peptide sequence Accession number Protein
2.44 0.21 8.6 131.5 1012.90 1026.48 2 9 AEEDEILNRpSPR P17096 Nonhistone chromosomal protein HMG-I
2.41 0.15 6.3 104.4 691.32 700.38 3 9 IEDVGpSDEEDDSGKDKK P08238 Heat shock protein 90-beta
2.24 0.37 16.6 134.0 857.06 869.14 3 12 ESEDKPEIEDVGpSDEEEEKK P07900 Heat shock protein 90-alpha
1.62 0.31 19.3 14.69 620.68 625.68 3 5 SKGHYEVTGpSDDETGK AHNK_HUMAN_2 Neuroblast differentiation associated protein AHNAK
1.33 0.35 26.2 92.8 521.28 525.28 3 4 AGDLLEDpSPKRPK A55055 hepatoma-derived growth factor
1.26 0.13 10.4 94.9 789.88 797.44 2 5 AEEDEILNRpSPR NP_001737 Calnexin
1.15 0.09 8.1 62.4 481.23 485.75 2 3 LpSAEYEK Q02952 A-kinase anchor protein 12
1.02 0.10 9.5 177.4 801.93 806.43 2 3 pTSSEDNLYLAVLR AAF18070 Plectin isoform 1a
0.99 0.14 14.3 161.9 1034.38 1046.48 2 8 DWEDDpSDEDMSNFDR A56211 Progesterone receptor-related protein p23
0.87 0.11 12.3 121.6 587.98 591.98 3 4 RNpSSEASSGDFLDLK Q9UK76 HN1 protein
0.87 0.09 10.9 124.0 565.62 568.64 3 3 LKDLFDYpSPPLHK NP_055554 Bcl-2 associated transcription factor short form
0.86 0.08 9.1 144.5 696.01 704.07 3 8 GLLYDpSDEEDEERPAR P49736 DNA replication licensing factor MCM2
0.80 0.13 15.7 82.1 650.33 653.37 2 2 RIDIpSPSTFR NP_005110 Thyroid hormone receptor-associated protein
0.80 0.04 5.1 41.5 593.31 596.33 3 3 KKEPAITSQNpSPEAR S26831 Transcription elongation factor IIS
0.79 0.08 10.0 82.1 656.28 661.31 3 5 HQApSDpSENEELPKPR NP_060439 hypothetical protein FLJ10006
0.77 0.12 15.4 56.88 705.85 713.35 2 5 NFYEpSDDDQK T50652 AP-3 complex beta3A chain [imported]-human.
0.75 0.02 3.0 115.80 783.06 787.06 3 4 pSHNNFVAILDLPEGEHQYK T09514 5-AMP-activated protein kinase beta-1 chain
0.74 0.17 22.2 37.3 479.23 482.25 2 2 DVYLpSPR Q96E39 Similar to RNA binding motif protein
0.73 0.04 5.9 137.2 702.81 707.35 2 3 ENSFGpSPLEFR BAA83713 RNA binding protein
0.71 0.13 18.8 87.1 536.68 539.73 2 2 pSFDYNYR O75494 TLS-associated protein TASR-2
0.68 0.16 23.7 71.3 503.76 506.77 2 2 pTSPPLLDR BAA83717 RNA binding protein
0.67 0.09 13.8 56.0 438.21 439.72 2 1 TFpSATVR NP_055131 Calcium-regulated heat-stable protein
0.67 0.06 8.6 178.0 643.33 646.35 3 3 SLSpTSGESLYHVLGLDK S70515 Cysteine string protein 1
0.65 0.02 3.1 123.3 556.28 229.30 2 2 GlpSPIVFDR Q96MU7 Putative splicing factor YT521
0.62 0.03 4.2 97.1 803.73 808.35 2 3 pSPpSPEPIYNSEGK G02919 Transcription factor ZFM1
0.62 0.03 4.7 174.3 705.67 713.72 3 8 IYHLPDAEpSDEDEDFK BAA05893 Neural precursor cell expressed
0.61 0.10 16.0 208.5 1061.38 1074.96 2 9 EEpSEEpSDEDMGFGLFD Q9BVK4 Ribosomal protein, large P0
0.59 0.05 9.3 76.9 576.77 578.28 2 1 SSMpSGLHLVK S41121 Acetyl-CoA carboxylase
0.57 0.19 33.7 110.2 440.21 441.72 2 1 LSGFpSFK NP_032564 Myristoylated alanine-rich C-kinase substrate
0.53 0.08 15.1 87.0 592.29 595.32 2 2 QLpSSGVSEIR AAH12292 Similar to heat shock 27 kDa protein
0.46 0.09 19.3 41.43 445.25 448.25 2 2 SVVpSFDK AAC00056 Hsp27 ERE-TATA-binding protein
0.42 0.02 3.9 107.9 656.79 661.33 2 3 pSGSYSYLEER AAM49717 Myosin phosphatase target subunit 1
0.37 0.10 26.0 77.5 479.24 483.26 3 4 SEpSPKEPEQLR NP_002127 Heterogeneous ribonuclear particle protein A1.beeta
0.13 0.03 22.1 96.0 423.21 424.73 2 1 LSGLpSFK NP_075385 Myristylated alanine-rich protein kinase C substrate
0.10 0.03 34.2 0.0 630.29 635.54 4 7 FApSEDEHDEHDENGATGPVKR I37989 La 4.1 protein (human fragment)
1Samples of serum stimulated (Heavy) and serum starved (Light) were compared.
2H/L ratios were obtained from three independent esterification, IMAC and LC/MS experiments.
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